In this Pharma's Almanac roundtable, Andy Lewis, Chief Scientific Officer, weighs in on how life science technology providers support the #pharma industry and discusses the growing movement toward more digitally connected operations. Read the full article here: https://bit.ly/46q1NoY
Quotient Sciences
Pharmaceutical Manufacturing
Nottingham, Nottinghamshire 19,216 followers
Molecule to cure. Fast.
About us
Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast. We employ over 1,300 staff and operate from state-of-the-art manufacturing and clinical facilities in the US and UK. Our people make Quotient Sciences a special place to work. We are a dedicated team passionate about innovating and transforming drug development to help our customers develop new medicines for patients in need. We recruit people that are committed to making a difference, who excel at customer service and are always willing to go the extra mile. Teamwork is integral to our culture and success — helping, supporting and mentoring run through our DNA. Expect to join an empowering and innovative culture, where we encourage continuous improvement and offer opportunities to learn and develop every day.
- Website
-
https://bit.ly/3u9sI6l
External link for Quotient Sciences
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Nottingham, Nottinghamshire
- Type
- Privately Held
- Specialties
- CDMO, Formulation Development, Phase I & II Clinical Trial Manufacturing, Translational Pharmaceutics, High Potency Handling, Real-time Adaptive Manufacturing, Commercial Manufacturing, Solubility Enhancement, Modified Release, Pediatric Formulation Development, CRO, First-in-Human, Clinical Pharmacology, Relative Bioavailability, Pharmacokinetics, Drug-Drug Interaction, Human ADME / 14C, Data Sciences, Modelling & Simulation, Drug Substance, Scintigraphy, Bioanalysis, Isotope Labelling, Clinical Trial Supplies, Bioequivalence, Healthy Volunteer Studies, Proof-of-Concept, Drug Development, and Dosage Form Development
Products
Locations
Employees at Quotient Sciences
Updates
-
In this first video of this #miniseries, hear from Alejandra Ugalde, Screening Manager at our Miami facility. Learn about this role and what it's like to work here at #QuotientSciences. Check out more on our Miami location here: https://bit.ly/4dapggc
-
Hear from Asma Patel, VP of Integrated Development Services, to discover more about our company and life at #QuotientSciences. Learn more: https://bit.ly/3WDqUS2
-
In our latest #webinar, Dr. Andy Lewis, Chief Scientific Officer, and Dr. Stuart Mair, Chief Medical Officer, explore the latest developments in orally delivered #GLP-1 agonists and take a look at potential future innovations. Watch the full recording here: https://bit.ly/3WEKa0j
-
-
In our latest #blog by Paige Bellis, learn about microwave digestion, how we use this technique in our #bioanalysis work, and explore the benefits of using an ultraWAVE digester. Read more here: https://bit.ly/46kX1sO
-
-
Our US Garnet Valley facility is focused on developing #smallmolecule oral drug products, supporting development programs from the #preclinical stage through to #clinical proof-of-concept. Learn more about our #GarnetValley site: https://bit.ly/3Y07R5w
-
Join us for our seminar & drinks reception this September in Geneva, Switzerland. Led by John McDermott, this event will offer a chance to hear case studies on reformulation programs and develop an understanding of #TranslationalPharmaceutics® when applied to #drugproduct optimization. Register today: https://bit.ly/3YjpnBF
This content isn’t available here
Access this content and more in the LinkedIn app
-
Check out this Pharma's Almanac article on current investment trends within the #pharma industry featuring Andy Lewis, our Chief Scientific Officer.
In case you missed it:this new Pharma's Almanac roundtable, a panel of industry experts weighs in on the most impactful investment trends influencing pharma and biopharma. This roundtable features contributors from: Alconox Inc., TriRx Pharmaceutical Services, LLC, Sonata Therapeutics, Flagship Pioneering, GBI Biomanufacturing, Fab Biopharma, Quotient Sciences, Mikart, LLC, Oxford Biomedica, PCI Pharma Services, Samsung Biologics, Simtra BioPharma Solutions, Cambrex, Astrea Bioseparations, N4 Pharma Plc, Lonza, SK pharmteco, Center for Breakthrough Medicines, Epocrates Inc, Thermo Fisher Scientific, OM1, Inc., Bruker BioSpin, MilliporeSigma, Certara, Seer, eClinical Solutions, Spinogenix, Inc., ProPharma, ScaleReady, REITHERA, eXmoor Pharma, NextCell Pharma AB, OrganoBiotech, Inc., and Catalent Pharma Solutions See the full roundtable here: https://lnkd.in/g3C3Dj7B
-
-
Quotient Sciences promotes a science-led approach to projects for our customers, and our Project Managers, like Yolanda Gibson, make sure that programs are delivered as smoothly as possible. Read what Yolanda has to say about her role and working at our global HQ in Nottingham: https://bit.ly/3HVEZ4W
-
Inclusivity is one of our cornerstone values at #QuotientSciences and our aim is to achieve a sense of acceptance and belonging for every person in our organization. Last month, each of our sites hosted #pride events, check out some of the photos here.
-
-
-
-
-
1
-